Simultaneous fMRI and TUS-based Neurostimulation

Summary

We are seeking healthy adults to participate in a brain imaging (MRI) study. Your participation will contribute to research that aims to explore the feasibility and effectiveness of a neurostimulation technique called Transcranial Ultrasound Stimulation (TUS). The research study aims to help develop non-invasive treatments for various neurological and psychiatric disorders. The time commitment for this study requires five in-person visits of 2-3 hours each at the Seaman Family MR Research Centre at Foothills Hospital and one remote questionnaire.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 40

Accepts healthy participants: Yes

Inclusion criteria:

• Aged 18-40
• Healthy
• Availability to participate in all sessions over five weeks
• Normal to corrected vision
• Normal hearing

Exclusion criteria:

• Implanted devices (e.g., pacemaker)
• Pregnancy
• History of neurological or psychiatric disorders
• Personal or family history of seizures, mood, or cardiovascular disorder
• Ear trauma
• Alcohol or drug dependency
• Use of prescription medications for mental health or blood pressure
• Legal incapacity
• Inability to communicate with research staff

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Please contact Courtney Collins at courtney.collins@ucalgary.ca or 403-210-6739 for more information.

Principal investigator:

G. Bruce Pike

Clinical trial:

No

REB-ID:

REB24-1003